Answers are grounded in this paper and cite their sources.
CF-LVAD-supported patients have a significant risk of GI bleeding that is mainly caused by arteriovenous malformations located in the upper GI tract. The increased prevalence of GI bleeding in CF-LVAD patients is attributed to several etiologies that include factors attributed to the device itself and extrinsic factors such as the use of anticoagulation.
No takes yet. Share an insight, caveat, or question.
Rio‐Pertuz et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: